Mehrotra R, Yadav K. Breast cancer in India: Present scenario and the challenges ahead. World J Clin Oncol 2022; 13(3): 209-218 [PMID: 35433294 DOI: 10.5306/wjco.v13.i3.209]
Corresponding Author of This Article
Ravi Mehrotra, MBBS, MD, PhD, Director, Doctor, Department of Health Research, Ministry of Health and Family Welfare, India Cancer Research Consortium, New Delhi 110001, India. ravi.mehrotra@gov.in
Research Domain of This Article
Oncology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Oncol. Mar 24, 2022; 13(3): 209-218 Published online Mar 24, 2022. doi: 10.5306/wjco.v13.i3.209
Breast cancer in India: Present scenario and the challenges ahead
Ravi Mehrotra, Kavita Yadav
Ravi Mehrotra, Department of Health Research, Ministry of Health and Family Welfare, India Cancer Research Consortium, New Delhi 110001, India
Ravi Mehrotra, CHIP Foundation, Noida 201301, India
Kavita Yadav, Centre of Social Medicine & Community Health, Jawahar Lal Nehru University, New Delhi 110067, India
Author contributions: Both authors (Mehrotra R and Yadav K) contributed equally to all aspects of the paper preparation.
Conflict-of-interest statement: The authors declare no potential conflict of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ravi Mehrotra, MBBS, MD, PhD, Director, Doctor, Department of Health Research, Ministry of Health and Family Welfare, India Cancer Research Consortium, New Delhi 110001, India. ravi.mehrotra@gov.in
Received: April 9, 2021 Peer-review started: April 9, 2021 First decision: June 7, 2021 Revised: June 17, 2021 Accepted: March 7, 2022 Article in press: March 7, 2022 Published online: March 24, 2022
Abstract
Breast cancer is the commonest malignancy among women globally. From being fourth in the list of most common cancers in India during the 1990s, it has now become the first. In this review, we examine the available literature to understand the factors that contributed to the high burden of breast cancer in the country. We also provide the landscape of changes in the field of early diagnosis and the treatment modalities as well as the limitations of the Indian healthcare delivery systems (e.g., delayed diagnosis, human resources and funding for treatment). This review also sheds light on the newer interventions and the future of breast cancer management keeping in mind the coronavirus disease 2019 imposed limitations.
Core Tip: This review highlights the progress that has been made in the field of breast cancer management in India over the past few decades, in terms of addressing the various challenges of breast cancer control including diagnostic methods and treatment options. It also highlights the future of breast cancer control strategies with a focus on the coronavirus disease 2019 situation.
